American Century Companies
KROS icon

American Century Companies’s Keros Therapeutics KROS Stock Holding History

American Century Companies’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$709K Buy
64,260
+27,620
+75% +$427K ﹤0.01% 2429
2025
Q4 		$746K Sell
36,640
-2,526
-6% -$44.3K ﹤0.01% 2404
2025
Q3 		$620K Buy
+39,166
New +$579K ﹤0.01% 2451
2025
Q1 		– Sell
-328,920
Closed -$5.21M – 2918
2024
Q4 		$5.21M Buy
328,920
+31,251
+10% +$1.62M ﹤0.01% 1586
2024
Q3 		$17.3M Sell
297,669
-501
-0.2% -$24.7K 0.01% 1087
2024
Q2 		$13.6M Buy
298,170
+59,364
+25% +$3.19M 0.01% 1116
2024
Q1 		$15.8M Buy
238,806
+24,209
+11% +$1.44M 0.01% 1019
2023
Q4 		$8.53M Buy
214,597
+523
+0.2% +$16.4K 0.01% 1211
2023
Q3 		$6.82M Buy
214,074
+71
+0% +$2.65K 0.01% 1218
2023
Q2 		$8.6M Buy
214,003
+100,860
+89% +$4.42M 0.01% 1122
2023
Q1 		$4.82M Buy
+113,143
New +$5.71M ﹤0.01% 1275

Other funds holding KROS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return